First-in-Human Study of the EZH1/2 Dual Inhibitor Valemetostat in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) - Updated Results Focusing on Adult T-Cell Leukemia-Lymphoma (ATL)
暂无分享，去创建一个
A. Utsunomiya | K. Izutsu | K. Tobinai | K. Tsukasaki | K. Ishitsuka | T. Ishida | Y. Imaizumi | S. Kusumoto | R. Atsumi | K. Araki | S. Morishima | K. Nosaka | N. Yamauchi | J. Makiyama | Tomonari Yamashita | Nobuaki Adachi